Nuvation Bio Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Nuvation Bio Inc. reported Cash And Cash Equivalents At Carrying Value of $164.09 million for the year ending 2025.

  • Nuvation Bio Inc. showed an increase of +359.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Nuvation Bio Inc.'s annual report (Form 10-K), filed with the SEC on March 2, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2025: $164.09 million | Fiscal year 2024: $35.72 million | Fiscal year 2023: $42.65 million | Fiscal year 2022: $101.10 million | Fiscal year 2021: $132.42 million | Fiscal year 2020: $29.76 million | Fiscal year 2020: $0.00.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: